TFDA-2024-0091-V291
Type II variation for application TFDA-2024-0091. Type II variation: Container Closure Change for Lorlatenilib — minor update
Variation Number
TFDA-2024-0091-V291
Type
Type II
Application
Change
Status
Failed
Fee
€52,324
Submitted
2024-01-01
Approved
—
Description
Type II variation: Container Closure Change for Lorlatenilib — minor update